Methimazole (MMI) is a pharmaceutical specifically designed to treat hyperthyroidism by inhibiting thyroperoxidase (TPO), while the herbicide amitrole has unintentional TPO-inhibiting properties. This evidence concerns the gene TPO and hyperthyroidism.